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Background
The challenges of quickly obtaining the necessary research
approvals to open multisite clinical trials in the UK, is well
documented.
This presentation takes a fresh, in depth look at the
factors currently limiting the efficient set up of multi-
centre clinical trials. We seek to discover whether newly
imposed timeframes and penalties aimed at improving
the speed of local NHS R&D governance checks have
had the desired impact, and if so, what other activities
are impacting the time taken to open research sites.
Methods
We present a case study of two trials, SANADII, a CTIMP
trial aiming to recruit 1500 participants across 100+ sites
and BASICS, a medical device trial, aiming to recruit 1200
participants over 17 sites. Both trials seek to have research
sites across all four UK constituent nations.
Primary, secondary and tertiary delays affecting progress
were recorded for sites from ethical approval to opening
to recruitment. Key milestones such as SSI submission,
gaining R&D approval, signing contracts and initiation
training were also recorded for each site along with over-
arching trial milestones.
We identified sites that encountered significant delays
for further analysis, looking at which milestones and
activities regularly contributed to delays.
Results
Early data suggests local research governance checks
may no longer be such a limiting factor, but that other
administration, document collection, and accessibility of
research staff contribute significant delays.
Full analysis of the results will be presented with
suggestions of how clinical trial governance should be
developed to minimise impact of the reoccurring
delays identified.
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